/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Biofrontera Inc Share Price Today: Live Updates & Key Insights

Biofrontera Inc share price today is $1.08, up 0%. The stock opened at $1.07 against the previous close of $1.09, with an intraday high of $1.085 and low of $1.07.

Biofrontera Inc Share Price Chart

style
pb-0

Biofrontera Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Biofrontera Inc Share Price Performance

$1.08 0(0%) BFRI at 27 Jul 2026 02:09 PM Drug Manufacturers - Specialty & Generic
Lowest Today 1.07
Highest Today 1.085
Today’s Open 1.07
Prev. Close 1.09
52 Week High 1.21
52 Week Low 0.55
Day’s Range: Low 1.07 High 1.085
52-Week Range: Low 0.55 High 1.21
1 day return -
1 Week return +0.94
1 month return +12.52
3 month return -5.3
6 month return +9.16
1 year return -0.92
3 year return -91.23
5 year return -98.79
10 year return -

Biofrontera Inc Institutional Holdings

Rosalind Advisors, Inc. 9.09

AIGH Capital Management, LLC 7.15

Vanguard Group Inc 0.89

Geode Capital Management, LLC 0.85

Fidelity Extended Market Index 0.60

Vanguard Institutional Extnd Mkt Idx Tr 0.56

Vanguard Fiduciary Trust Co 0.48

Vanguard Capital Management, LLC 0.41

Susquehanna International Group, LLP 0.30

XTX Topco Ltd 0.18

NT Ext Equity Mkt Index Fund - Lending 0.17

Spartan Extended Market Index Pool F 0.10

Citigroup Inc 0.09

NT Ext Equity Mkt Index Fund - NL 0.08

Sanctuary Advisors, LLC 0.08

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Fidelity Series Total Market Index 0.06

BlackRock Inc 0.04

Spartan Total Market Index Pool G 0.02

UBS Group AG 0.01

Fidelity Total Market Index 0.00

Northern Trust Extended Eq Market Idx 0.00

SBI Securities Co Ltd 0.00

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.00

State St US Extended Mkt Indx NL Cl C 0.00

State St US Ttl Mkt Idx NL Cl A 0.00

SSgA U.S. Total Market Index Strategy 0.00

BlackRock Extended Equity Market Fund K 0.00

Blackrock Extended Mkt Fund CF 0.00

Blackstone Alternative Multi-Strategy I 0.00

Extended Equity Market Fund B 0.00

Extended Equity Market Fund E 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Bank of America Corp 0.00

Hunter Associates Inc. 0.00

Jane Street Group LLC 0.00

Renaissance Technologies Corp 0.00

TWO SIGMA SECURITIES, LLC 0.00

Biofrontera Inc Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Biofrontera Inc Fundamentals

Market Cap 13.96 M

PB Ratio 2.2569

PE Ratio 0.0

Enterprise Value 15.23 M

Total Assets 28.56 M

Volume 165983

Biofrontera Inc Company Financials

Annual Revenue FY23:33619000 33.6M, FY22:28674000 28.7M, FY21:24100000 24.1M, FY20:18849000 18.8M, FY19:26181000 26.2M

Annual Profit FY23:16287000 16.3M, FY22:13489000 13.5M, FY21:11358000 11.4M, FY20:9783000 9.8M, FY19:13773000 13.8M

Annual Net worth FY23:-26442000 -26.4M, FY22:-640000 -0.6M, FY21:-37713000 -37.7M, FY20:-10987000 -11.0M, FY19:-10982000 -11.0M

Quarterly Revenue Q1/2026:10084000 10.1M, Q3/2025:6988000 7.0M, Q2/2025:9030000 9.0M, Q1/2025:8588000 8.6M, Q3/2024:9012000 9.0M

Quarterly Profit Q1/2026:8253000 8.3M, Q3/2025:5066000 5.1M, Q2/2025:6650000 6.7M, Q1/2025:5513000 5.5M, Q3/2024:4135000 4.1M

Quarterly Net worth Q1/2026:-4752000 -4.8M, Q3/2025:-6649000 -6.6M, Q2/2025:-5324000 -5.3M, Q1/2025:-4203000 -4.2M, Q3/2024:-5669000 -5.7M

About Biofrontera Inc & investment objective

Company Information Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Organisation Drug Manufacturers - Specialty & Generic

Employees 84

Industry Drug Manufacturers - Specialty & Generic

CEO Dr. Hermann Luebbert Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Biofrontera Inc FAQs

What is the share price of Biofrontera Inc today?

The current share price of Biofrontera Inc is $1.08.

Can I buy Biofrontera Inc shares in India?

Yes, Indian investors can buy Biofrontera Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Biofrontera Inc shares in India?

You can easily invest in Biofrontera Inc shares from India by:

Can I buy fractional shares of Biofrontera Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Biofrontera Inc?

Biofrontera Inc has a market cap of $13.96 M.

In which sector does Biofrontera Inc belong?

Biofrontera Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Biofrontera Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Biofrontera Inc?

The PE ratio of Biofrontera Inc is N/A and the PB ratio is 2.26.